This partnership is designed to meet the growing demand for oncology research, tapping into South Africa’s diverse, treatment-naïve population and its advanced clinical sites. With South Africa’s age-standardized cancer rate at 203.4 per 100,000 people¹, we see an incredible opportunity to accelerate cancer treatments and bring innovative therapies to patients in need.
- By aligning our strengths, we’re able to offer:
- Seamless, high-quality trial management from study design through to execution
- Accelerated study timelines through streamlined regulatory approvals and site start-ups
- Access to top-tier investigators and facilities
- A shared commitment to improving healthcare globally
Our combined experience in oncology research, paired with our established presence in South Africa, ensures efficient patient recruitment, superior clinical oversight, and world-class facilities. Together, we’re creating a powerful platform for advancing cancer research and delivering life-saving therapies to patients faster.
We are excited to work towards a shared goal of better healthcare for all!
1 Reference: Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer.
Available from: https://lnkd.in/dbFemzCM, accessed 2 October 2024.